BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19683949)

  • 1. Involvement of transient receptor potential vanilloid 1 receptors in protease-activated receptor-2-induced joint inflammation and nociception.
    Helyes Z; Sándor K; Borbély E; Tékus V; Pintér E; Elekes K; Tóth DM; Szolcsányi J; McDougall JJ
    Eur J Pain; 2010 Apr; 14(4):351-8. PubMed ID: 19683949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism.
    Russell FA; Veldhoen VE; Tchitchkan D; McDougall JJ
    J Neurophysiol; 2010 Jan; 103(1):155-63. PubMed ID: 19889854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways.
    Martin L; Augé C; Boué J; Buresi MC; Chapman K; Asfaha S; Andrade-Gordon P; Steinhoff M; Cenac N; Dietrich G; Vergnolle N
    Pain; 2009 Nov; 146(1-2):121-9. PubMed ID: 19674841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice.
    Szabó A; Helyes Z; Sándor K; Bite A; Pintér E; Németh J; Bánvölgyi A; Bölcskei K; Elekes K; Szolcsányi J
    J Pharmacol Exp Ther; 2005 Jul; 314(1):111-9. PubMed ID: 15831443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice.
    McDougall JJ; Zhang C; Cellars L; Joubert E; Dixon CM; Vergnolle N
    Arthritis Rheum; 2009 Mar; 60(3):728-37. PubMed ID: 19248120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia.
    Sipe WE; Brierley SM; Martin CM; Phillis BD; Cruz FB; Grady EF; Liedtke W; Cohen DM; Vanner S; Blackshaw LA; Bunnett NW
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1288-98. PubMed ID: 18325985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation.
    Keeble J; Russell F; Curtis B; Starr A; Pinter E; Brain SD
    Arthritis Rheum; 2005 Oct; 52(10):3248-56. PubMed ID: 16200599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
    Sándor K; Helyes Z; Elekes K; Szolcsányi J
    Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia.
    Kanai Y; Hara T; Imai A; Sakakibara A
    J Pharm Pharmacol; 2007 May; 59(5):733-8. PubMed ID: 17524240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw.
    Paszcuk AF; Quintão NL; Fernandes ES; Juliano L; Chapman K; Andrade-Gordon P; Campos MM; Vergnolle N; Calixto JB
    Eur J Pharmacol; 2008 Feb; 581(1-2):204-15. PubMed ID: 18083162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia.
    Kawamata T; Ji W; Yamamoto J; Niiyama Y; Furuse S; Namiki A
    Neuroscience; 2008 Jun; 154(3):1067-76. PubMed ID: 18495351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat.
    Kasama S; Kawakubo M; Suzuki T; Nishizawa T; Ishida A; Nakayama J
    Eur J Neurosci; 2007 May; 25(10):2956-63. PubMed ID: 17509082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transient receptor potential vanilloid 4 in rat joint inflammation.
    Denadai-Souza A; Martin L; de Paula MA; de Avellar MC; Muscará MN; Vergnolle N; Cenac N
    Arthritis Rheum; 2012 Jun; 64(6):1848-58. PubMed ID: 22184014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis.
    Xu GY; Winston JH; Shenoy M; Yin H; Pendyala S; Pasricha PJ
    Gastroenterology; 2007 Oct; 133(4):1282-92. PubMed ID: 17698068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons.
    Alier KA; Endicott JA; Stemkowski PL; Cenac N; Cellars L; Chapman K; Andrade-Gordon P; Vergnolle N; Smith PA
    J Pharmacol Exp Ther; 2008 Jan; 324(1):224-33. PubMed ID: 17921188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of the TRPV1 receptor in the development of acute gout attacks.
    Hoffmeister C; Silva MA; Rossato MF; Trevisan G; Oliveira SM; Guerra GP; Silva CR; Ferreira J
    Rheumatology (Oxford); 2014 Feb; 53(2):240-9. PubMed ID: 24185761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of TRPV1 in nociceptive behavior in a rat model of cancer pain.
    Shinoda M; Ogino A; Ozaki N; Urano H; Hironaka K; Yasui M; Sugiura Y
    J Pain; 2008 Aug; 9(8):687-99. PubMed ID: 18455478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
    Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
    J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat.
    Varga A; Németh J; Szabó A; McDougall JJ; Zhang C; Elekes K; Pintér E; Szolcsányi J; Helyes Z
    Neurosci Lett; 2005 Sep; 385(2):137-42. PubMed ID: 15950380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.